Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Kina vs Sumbare Wellness

Kina
Graded #107

Higher grade

vs+8.199999999999996
Sumbare Wellness
Graded #281

Lower grade

The verdict

Kina takes it — 70.1/100 to 61.9/100.

Kina grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSumbare Wellness +5
61
66
Dose & formulationSumbare Wellness +8
64
72
Clinical oversightKina +32
88
56
Labs & monitoringKina +12
64
52
FulfillmentKina +24
83
59
Contract termsEven
61
61
Kina · left barSumbare Wellness · right bar

The numbers

MetricKinaSumbare Wellness
WeighScore70.1/10061.9/100
GradeCC
Scorecard rank#107#281
Semaglutide$179/mo (starting dose, plus a separate fee, compounded)$199/mo (all doses, compounded)
Tirzepatide$179/mo (starting dose, compounded)$199/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Kina

Graded #107 · C

Strengths

  • Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
  • Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
  • Verifiable LegitScript certification (seal ID 50917967)
  • GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
  • Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake

Where it loses points

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Built for women navigating menopause — less tailored if that is not your situation
  • A separate $50 physician consultation fee applies on top of the medication price
  • The compounding pharmacy partner is not named, and the full list of served states is not published
Sumbare Wellness

Graded #281 · C

Strengths

  • One flat $199/month price covering medication, provider review and shipping, with no consultation fee and no dose-change surcharge
  • Charges nothing if a provider does not approve you
  • Offers a deliberate low-dose microdosing protocol aimed at body composition, which most competitors do not break out
  • Publishes a named legal entity, a US mailing address and a working phone number
  • Pre-screening quiz is short and asks your goal before any medical question

Where it loses points

  • Cancellation terms contradict three ways: the homepage says cancel anytime, the Terms say 48 hours notice, the FAQ says 30 days
  • Availability is unclear: the homepage counter reads 3 states while the treatment pages say telehealth nationwide, and no state list is published
  • Its chart cites placebo-controlled trials of compounded semaglutide and tirzepatide, which do not exist; those trials studied the branded drugs
  • No compounding pharmacy is named, and neither 503A nor 503B appears anywhere on the site
  • Any returned prescription is charged a $35 disposal fee, and prescription orders cannot be cancelled at all after 24 hours

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard